Biomarker Technologies Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Biomarker Technologies Market

1.1. Definition and Scope

1.1.1. Definition of Biomarker Technologies

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Biomarker Technologies Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Biomarker Technologies Market By Test Type

1.2.3. Biomarker Technologies Market By Product

1.2.4. Biomarker Technologies Market By Technology

1.2.5. Biomarker Technologies Market By Application

1.2.6. Biomarker Technologies Market By Indication

1.2.7. Biomarker Technologies Market By Region

CHAPTER 2. Immunoassay Approach

2.1. Methodology 

2.1.1. Immunoassay Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Biomarker Technologies Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Biomarker Technologies Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2022

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Biomarker Technologies Market By Test Type

4.1. Introduction

4.2. Biomarker Technologies Revenue By Test Type

4.2.1. Biomarker Technologies Revenue (USD Million) and Forecast, By Test Type, 2020-2032

4.2.2. Solid Biopsy

4.2.2.1. Solid Biopsy Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3. Liquid Biopsy

4.2.3.1. Liquid Biopsy Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 5. Biomarker Technologies Market By Product

5.1. Introduction

5.2. Biomarker Technologies Revenue By Product

5.2.1. Biomarker Technologies Revenue (USD Million) and Forecast, By Product, 2020-2032

5.2.2. Consumables

5.2.2.1. Consumables Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. Instruments

5.2.3.1. Instruments Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4. Services

5.2.4.1. Services Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5. Software/Informatics

5.2.5.1. Software/Informatics Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 6. Biomarker Technologies Market By Technology

6.1. Introduction

6.2. Biomarker Technologies Revenue By Technology

6.2.1. Biomarker Technologies Revenue (USD Million) and Forecast, By Technology, 2020-2032

6.2.2. DdPCR

6.2.2.1. DdPCR Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. NGS

6.2.3.1. NGS Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.4. Immunoassay

6.2.4.1. Immunoassay Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.5. Mass Spectrometry

6.2.5.1. Mass Spectrometry Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.6. DHPLC

6.2.6.1. DHPLC Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.7. Other Technologies

6.2.7.1. Other Technologies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 7. Biomarker Technologies Market By Application

7.1. Introduction

7.2. Biomarker Technologies Revenue By Application

7.2.1. Biomarker Technologies Revenue (USD Million) and Forecast, By Application, 2020-2032

7.2.2. Drug Discovery

7.2.2.1. Drug Discovery Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3. Diagnostics

7.2.3.1. Diagnostics Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.4. Personalized Medicine

7.2.4.1. Personalized Medicine Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 8. Biomarker Technologies Market By Indication

8.1. Introduction

8.2. Biomarker Technologies Revenue By Indication

8.2.1. Biomarker Technologies Revenue (USD Million) and Forecast, By Indication, 2020-2032

8.2.2. Cancer

8.2.2.1. Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.3. Infectious Diseases

8.2.3.1. Infectious Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.4. Autoimmune Disorders

8.2.4.1. Autoimmune Disorders Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.5. Cardiovascular Disorders

8.2.5.1. Cardiovascular Disorders Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.6. Others

8.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 9. North America Biomarker Technologies Market By Country 

9.1. North America Biomarker Technologies Market Overview

9.2. U.S.

9.2.1. U.S. Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

9.2.2. U.S. Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

9.2.3. U.S. Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

9.2.4. U.S. Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

9.2.5. U.S. Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

9.3. Canada

9.3.1. Canada Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

9.3.2. Canada Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

9.3.3. Canada Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

9.3.4. Canada Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

9.3.5. Canada Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

9.4. North America PEST Analysis

CHAPTER 10. Europe Biomarker Technologies Market By Country

10.1. Europe Biomarker Technologies Market Overview

10.2. U.K.

10.2.1. U.K. Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

10.2.2. U.K. Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

10.2.3. U.K. Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

10.2.4. U.K. Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

10.2.5. U.K. Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

10.3. Germany

10.3.1. Germany Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

10.3.2. Germany Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

10.3.3. Germany Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

10.3.4. Germany Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

10.3.5. Germany Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

10.4. France

10.4.1. France Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

10.4.2. France Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

10.4.3. France Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

10.4.4. France Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

10.4.5. France Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

10.5. Spain

10.5.1. Spain Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

10.5.2. Spain Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

10.5.3. Spain Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

10.5.4. Spain Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

10.5.5. Spain Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

10.6. Rest of Europe

10.6.1. Rest of Europe Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

10.6.2. Rest of Europe Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

10.6.3. Rest of Europe Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

10.6.4. Rest of Europe Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

10.6.5. Rest of Europe Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Biomarker Technologies Market By Country

11.1. Asia Pacific Biomarker Technologies Market Overview

11.2. China

11.2.1. China Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

11.2.2. China Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

11.2.3. China Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

11.2.4. China Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

11.2.5. China Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

11.3. Japan

11.3.1. Japan Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

11.3.2. Japan Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

11.3.3. Japan Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

11.3.4. Japan Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

11.3.5. Japan Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

11.4. India

11.4.1. India Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

11.4.2. India Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

11.4.3. India Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

11.4.4. India Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

11.4.5. India Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

11.5. Australia

11.5.1. Australia Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

11.5.2. Australia Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

11.5.3. Australia Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

11.5.4. Australia Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

11.5.5. Australia Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

11.6. South Korea

11.6.1. South Korea Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

11.6.2. South Korea Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

11.6.3. South Korea Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

11.6.4. South Korea Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

11.6.5. South Korea Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

11.7.2. Rest of Asia-Pacific Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

11.7.3. Rest of Asia-Pacific Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

11.7.4. Rest of Asia-Pacific Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

11.7.5. Rest of Asia-Pacific Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Biomarker Technologies Market By Country

12.1. Latin America Biomarker Technologies Market Overview

12.2. Brazil

12.2.1. Brazil Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

12.2.2. Brazil Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

12.2.3. Brazil Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

12.2.4. Brazil Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

12.2.5. Brazil Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

12.3. Mexico

12.3.1. Mexico Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

12.3.2. Mexico Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

12.3.3. Mexico Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

12.3.4. Mexico Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

12.3.5. Mexico Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

12.4. Rest of Latin America

12.4.1. Rest of Latin America Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

12.4.2. Rest of Latin America Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

12.4.3. Rest of Latin America Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

12.4.4. Rest of Latin America Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

12.4.5. Rest of Latin America Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Biomarker Technologies Market By Country 

13.1. Middle East & Africa Biomarker Technologies Market Overview

13.2. GCC

13.2.1. GCC Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

13.2.2. GCC Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

13.2.3. GCC Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

13.2.4. GCC Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

13.2.5. GCC Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

13.3. South Africa

13.3.1. South Africa Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

13.3.2. South Africa Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

13.3.3. South Africa Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

13.3.4. South Africa Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

13.3.5. South Africa Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Biomarker Technologies Revenue (USD Million) and Forecast By Product, 2020-2032

13.4.2. Rest of Middle East & Africa Biomarker Technologies Revenue (USD Million) and Forecast By Test Type, 2020-2032

13.4.3. Rest of Middle East & Africa Biomarker Technologies Revenue (USD Million) and Forecast By Technology, 2020-2032

13.4.4. Rest of Middle East & Africa Biomarker Technologies Revenue (USD Million) and Forecast By Application, 2020-2032

13.4.5. Rest of Middle East & Africa Biomarker Technologies Revenue (USD Million) and Forecast By Indication, 2020-2032

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of Biomarker Technologies Market

14.1. Biomarker Technologies Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Biomarker Technologies Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile

15.1. Agilent Technologies

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Million), 2022

15.1.3.2. Agilent Technologies 2022 Biomarker Technologies Business Regional Distribution

15.1.4. Product /Service and Specification

15.1.5. Recent Developments & Business Strategy

15.2. Bio-Rad Laboratories

15.3. Danaher Corporation

15.4. F. Hoffmann-La Roche AG

15.5. Illumina, Inc.

15.6. LI-COR, Inc.

15.7. Merck KGAA

15.8. PerkinElmer Inc.

15.9. QIAGEN

15.10. Roche

15.11. Shimadzu Corporation

15.12. Thermo Fisher Scientific

15.13. Waters Corporation